The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod

BACKGROUND: Fingolimod is a sphingosine 1-phosphate receptor modulator for the treatment of patients with relapsing forms of multiple sclerosis (RMS). Fingolimod sequesters lymphocytes within lymphoid tissue thereby reducing the counts of circulating lymphocytes. However, fingolimod’s effects on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Jeffrey A, Bar-Or, Amit, Cree, Bruce A C, Mao-Draayer, Yang, Han, May H, Singer, Barry, Jannu, Ann, Kolodny, Scott, Meng, Xiangyi, Winger, Ryan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318720/
https://www.ncbi.nlm.nih.gov/pubmed/30637116
http://dx.doi.org/10.1177/2055217318819245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318720/
https://www.ncbi.nlm.nih.gov/pubmed/30637116
http://dx.doi.org/10.1177/2055217318819245

Ejemplares similares